Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Shengtai Pharmaceutical, Inc Announces Appointment of New Chief Financial Office
Mar 04, 10 06:00AM
WEIFANG, Shandong, China, March 4 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board:SGTI.ob - News) ("Shengtai" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced in China that it has appointed Mr. Hu Ye as its new Chief Financial Officer.
Mr. Hu Ye received his degree of Master of Arts in Economics fromUniversity of Toronto, Canada, and his Bachelor's degree of Science in Electrical Engineering from Huazhong University of Science and Technology, China. Mr. Ye has been a Certified General Accountant (CGA) in Canada since 1998 and has over 20-year experience in financing and international capital markets.
Mr. Ye was the CFO of China Shen Zhou Mining & Resources, Inc. from June 2008 to March 2009 and the CFO of Si Mei Te Food Ltd. from May 2009 to September 2009. He worked in China as the CFO of Odysys International Ltd. from December 2003 to March 2006, CFO of BOCO Enterprises Ltd. from March 2006 toMarch 2007 and from December 2007 to May 2008, and CFO of EMarket Holding Group Corp. from March 2007 to November 2007. From January 2002 to September 2003 Mr. Ye was a consultant at Securitization Finance, CIT Group, Inc. in Canada. From June 1999 to March 2001 Mr. Ye was an Assistant Vice-President in Finance, Corporate and Institutional Client Group of Merrill Lynch Canada. From January 1990 to June 1999, Mr. Ye worked as a financial analyst of Finance and Tax, and a Financial Control Administrator at Mackenzie Financial Corporation in Canada.
Mr. Ye has been serving as Non-Executive Board Member of Beijing Heidrick & Struggles International Management Consulting Co. Ltd. since July 2006; Non- Executive Board Member of CIC Mining Resources Ltd. since February 2009.
Shengtai Pharmaceutical Inc. welcomes Mr. Hu Ye to join the company as CFO, and believes that Mr. Ye's financial background and experience will be a real asset to help move the company forward.
About Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary, Shengtai Holding, Inc. (SHI), a New Jerseycorporation, and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of pharmaceutical grade glucose used for medical purposes. It also manufactures and supplies glucose and cornstarch products to the food, beverage and industrial production industries inChina. For more information about Shengtai Pharmaceutical, Inc., please visit
For more information, please contact:
Shengtai Pharmaceutical, Inc. Mr. Hu Ye Chief Financial Officer Tel: +86-536-6295059 Email: email@example.com
Shengtai Pharmaceutical, Inc. Ms. Shenglian Iris Wang Investor Relations Manager Tel: +86-536-6295802 Email: firstname.lastname@example.org